Prevalence of Pancreatic Diabetes in Patients Carrying Mutations or Polymorphisms of the PRSS1 Gene in the Han Population

被引:21
作者
Liu, Qi-cai [1 ,6 ]
Zhuang, Ze-hao [2 ]
Zeng, Kai [3 ]
Cheng, Zu-jian [1 ,6 ]
Gao, Feng [4 ]
Wang, Zhi-qiang [5 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Dept Lab Med, Fuzhou 350005, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Fuzhou 350005, Peoples R China
[3] Fujian Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Fuzhou 350005, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Dept Pathol, Fuzhou 350005, Peoples R China
[5] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou 350005, Peoples R China
[6] Fujian Med Univ, Dept Gene Diag, Fuzhou 350005, Peoples R China
关键词
SERINE-PROTEASE INHIBITOR; HEREDITARY PANCREATITIS; CATIONIC TRYPSINOGEN; AUTOACTIVATION; ACTIVATION; MECHANISMS; CONVERSION; MELLITUS; DISEASE; TYPE-1;
D O I
10.1089/dia.2009.0051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study updated the estimated prevalence of type 3c diabetes damage to the pancreas through different genotypes of PRSS1 and their clinical characteristics in the Han population. Subjects and Methods: Cross-sectional analysis was performed of the most recent (2003-2007) patients with pancreatitis from six hospitals of the Han population in South China (n = 253). Results: There were 32 patients with pancreatitis carrying a PRSS1 gene abnormality within intron region among 253 cases of pancreatitis, including 27 patients carrying novel single nucleotide polymorphisms, namely, IVS 3 +75A -> G conversion, and five patients with the mutation IVS3 +10T -> G. Among these patients, there were only three cases of patients with diabetes (9.37%). This was lower than the prevalence of abnormalities in the exons of the PRSS1 gene (51.92%): 12 patients with c. 361 G -> A, eight patients with c. 415 T -> A, and five patients with c. 365G -> A. Among them were 12 persons with diabetes, including five requiring insulin to regulate blood sugar. What is more, among the 27 patients carrying PRSS1 gene polymorphism (c. 486 C -> T, within the exon 4), there were 15 persons with diabetes symptoms. More than 40% of these patients required insulin to regulate blood sugar. Conclusions: An abnormality within the intron region of the PRSS1 gene represents one of the causes of pancreatitis in Chinese patients, but it is not related to pancreatic diabetes. However, the exon abnormality obviously raises the morbidity rate of type 3c diabetes, which relies on insulin.
引用
收藏
页码:799 / 804
页数:6
相关论文
共 35 条
  • [1] Genetic testing - Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases
    Applebaum, SE
    Kant, JA
    Whitcomb, DC
    Ellis, IH
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (03) : 575 - +
  • [2] Challenges in human genetic diversity: demographic history and adaptation
    Balaresque, Patricia L.
    Ballereau, Stephane J.
    Jobling, Mark A.
    [J]. HUMAN MOLECULAR GENETICS, 2007, 16 : R134 - R139
  • [3] Gene conversion: mechanisms, evolution and human disease
    Chen, Jian-Min
    Cooper, David N.
    Chuzhanova, Nadia
    Ferec, Claude
    Patrinos, George P.
    [J]. NATURE REVIEWS GENETICS, 2007, 8 (10) : 762 - 775
  • [4] Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family study
    Chowdhury, ZM
    McDermott, MF
    Davey, S
    Hassan, Z
    Sinnott, PJ
    Hemmatpour, SK
    Sherwin, S
    Ali, L
    Aganna, E
    Allotey, RA
    North, BV
    Cassell, PG
    Khan, AKA
    Hitman, GA
    [J]. GENES AND IMMUNITY, 2002, 3 (01) : 5 - 8
  • [5] Chronic pancreatitis:: the perspective of pain generation by neuroimmune interaction
    Di Sebastiano, P
    di Mola, FF
    Bockman, DE
    Friess, H
    Büchler, MW
    [J]. GUT, 2003, 52 (06) : 907 - 911
  • [6] Chronic pancreatitis: Diagnosis, classification, and new genetic developments
    Etemad, B
    Whitcomb, DC
    [J]. GASTROENTEROLOGY, 2001, 120 (03) : 682 - 707
  • [7] European Nicotinamide Diabetes Intervention Trial (ENDIT):: a randomised controlled trial of intervention before the onset of type 1 diabetes
    Gale, EAM
    Bingley, PJ
    Knip, M
    Emmett, CL
    Swankie, H
    Fewell, S
    Kearsey, P
    Schober, E
    Gorus, FK
    Dupre, J
    Mahon, JL
    Profozic, V
    Reimers, JI
    Mandrup-Poulsen, T
    Levy-Marchal, C
    Jaeger, C
    Bartsocas, C
    Vazeou, A
    Györko, M
    Soltesz, G
    Madacsy, L
    Pastore, MR
    Pozzilli, P
    Dahl-Jorgensen, K
    Joner, G
    Kinalska, I
    Mrozikiewicz, A
    Vaykhonsky, Y
    de Leiva, A
    Martinez-Larrad, MT
    Mauricio, D
    Serrano-Rios, M
    Ludvigsson, J
    Schoenle, EJ
    Yilmaz, MT
    Carson, DJ
    Tennet, H
    Robertson, K
    Gillespie, KM
    Gillmor, H
    Moore, WPT
    Norcross, A
    Williams, AJK
    Dinesen, B
    Kjellberg, S
    Akelsen, HE
    Thorsby, E
    Undlien, DE
    Collier, T
    Hardy, P
    [J]. LANCET, 2004, 363 (9413) : 925 - 931
  • [8] Chronic pancreatitis and diabetes mellitus -: A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus
    Hardt, PD
    Killinger, A
    Nalop, J
    Schnell-Kretschmer, H
    Zekorn, T
    Klör, HU
    [J]. PANCREATOLOGY, 2002, 2 (01) : 30 - 33
  • [9] Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation
    Kiraly, Orsolya
    Wartmann, Thomas
    Sahin-Toth, Miklos
    [J]. GUT, 2007, 56 (10) : 1433 - 1438
  • [10] Hereditary pancreatitis caused by triplication of the trypsinogen locus
    Le Marechal, Cedric
    Masson, Emmanuelle
    Chen, Jian-Min
    Morel, Frederic
    Ruszniewski, Philippe
    Levy, Philippe
    Ferec, Claude
    [J]. NATURE GENETICS, 2006, 38 (12) : 1372 - 1374